Citigroup’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $74.8M | Buy |
1,591,334
+1,449,188
| +1,020% | +$68.1M | 0.04% | 331 |
|
2025
Q1 | $6.27M | Buy |
142,146
+27,081
| +24% | +$1.2M | ﹤0.01% | 1230 |
|
2024
Q4 | $4.16M | Buy |
115,065
+59,540
| +107% | +$2.15M | ﹤0.01% | 1573 |
|
2024
Q3 | $1.78M | Buy |
55,525
+20,030
| +56% | +$642K | ﹤0.01% | 2133 |
|
2024
Q2 | $1.34M | Sell |
35,495
-128,050
| -78% | -$4.82M | ﹤0.01% | 2046 |
|
2024
Q1 | $8.05M | Buy |
163,545
+83,769
| +105% | +$4.12M | 0.01% | 990 |
|
2023
Q4 | $2.91M | Buy |
79,776
+314
| +0.4% | +$11.5K | ﹤0.01% | 1412 |
|
2023
Q3 | $1.84M | Sell |
79,462
-8,458
| -10% | -$196K | ﹤0.01% | 1525 |
|
2023
Q2 | $2.31M | Sell |
87,920
-92,522
| -51% | -$2.43M | ﹤0.01% | 1574 |
|
2023
Q1 | $4.64M | Buy |
180,442
+39,428
| +28% | +$1.01M | ﹤0.01% | 1144 |
|
2022
Q4 | $3.67M | Sell |
141,014
-83,416
| -37% | -$2.17M | ﹤0.01% | 1201 |
|
2022
Q3 | $6.4M | Sell |
224,430
-29,632
| -12% | -$845K | ﹤0.01% | 996 |
|
2022
Q2 | $6.26M | Buy |
254,062
+234,558
| +1,203% | +$5.77M | ﹤0.01% | 1019 |
|
2022
Q1 | $1.1M | Sell |
19,504
-48,214
| -71% | -$2.72M | ﹤0.01% | 2260 |
|
2021
Q4 | $4.2M | Buy |
67,718
+29,692
| +78% | +$1.84M | ﹤0.01% | 1389 |
|
2021
Q3 | $2.41M | Sell |
38,026
-16,720
| -31% | -$1.06M | ﹤0.01% | 1772 |
|
2021
Q2 | $4.51M | Sell |
54,746
-1,942
| -3% | -$160K | ﹤0.01% | 1499 |
|
2021
Q1 | $4.17M | Buy |
56,688
+43,690
| +336% | +$3.21M | ﹤0.01% | 1444 |
|
2020
Q4 | $943K | Buy |
12,998
+9,483
| +270% | +$688K | ﹤0.01% | 2216 |
|
2020
Q3 | $167K | Sell |
3,515
-3,845
| -52% | -$183K | ﹤0.01% | 2871 |
|
2020
Q2 | $309K | Buy |
7,360
+3,062
| +71% | +$129K | ﹤0.01% | 2850 |
|
2020
Q1 | $116K | Buy |
4,298
+2,204
| +105% | +$59.5K | ﹤0.01% | 3204 |
|
2019
Q4 | $81K | Buy |
+2,094
| New | +$81K | ﹤0.01% | 3668 |
|